Key result
Continuation and maintenance ECT emerges as a safe and effective treatment for relapse- and recurrence-prone patients who have responded to a course of ECT.
Why the study?
Does continuation and maintenance ECT reduce the risk for relapse and recurrence of illness in patients who have responded to a course of ECT but fare poorly with medication regimens?
Does continuation and maintenance ECT reduce the risk for relapse and recurrence of illness in patients who have responded to a course of ECT but fare poorly with medication regimens?
Continuation and maintenance ECT appears to be a safe and effective strategy for preventing relapse in patients who responded to acute ECT but tolerate or respond poorly to maintenance medications.
May support maintenance ECT in select relapse-prone patients; leaves open need for randomized confirmation before broader adoption.
Continuation and maintenance electroconvulsive therapy (ECT) is used to reduce the risk for relapse and recurrence of illness in patients who fare poorly with continuation and maintenance medication regimens. Despite the potential value of these ECT schedules, both are relatively neglected in clinical practice. This article therefore reviews the last decade of research on the subject. Although the research comprises mostly single and multiple case reports and small open studies, continuation and maintenance ECT does emerge as a safe and effective treatment for relapse- and recurrence-prone patients who have responded to a course of ECT.
No takes yet. Share an insight, caveat, or question.
Andrade et al. (2002) conducted a review in Relapse- and recurrence-prone psychiatric illness. Continuation and maintenance electroconvulsive therapy (ECT) was evaluated. Continuation and maintenance ECT emerges as a safe and effective treatment for relapse- and recurrence-prone patients who have responded to a course of ECT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: